John Mascarenhas

Immunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19”.

Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19

Thrombosis Research(2020)10.1016/j.thromres.2020.08.032

N/A

5.6DataRank · unranked

130 citations

Nicole Zubizarreta, Jonathan Feld, Maaike van Gerwen, Mathilda Alsen, Santiago Thibaud +14 more

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Blood(2022)10.1182/blood.2021012743

N/A

3.6DataRank · unranked

129 citations

Heidi E. Kosiorek, Josef T. Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub +38 more

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

Blood Advances(2020)10.1182/bloodadvances.2020002119

N/A

2.2DataRank · unranked

73 citations

Raajit K. Rampal, Heidi Kosiorek, Rupali Bhave, Elizabeth O. Hexner, Eunice S. Wang +22 more

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial

Nature Medicine(2025)10.1038/s41591-025-03572-3

N/A

0.664DataRank · unranked

40 citations

Sebastian Grosicki, Dominik Chraniuk, Elisabetta Abruzzese, Prithviraj Bose, Aaron T. Gerds +23 more

Prevalence of Cytopenia in the General Population—A National Health and Nutrition Examination Survey Analysis

Frontiers in Oncology(2020)10.3389/fonc.2020.579075

N/A

0.396DataRank · unranked

13 citations

Joseph Rapp, John Mascarenhas, Eileen Scigliano, Douglas Tremblay, Bridget K. Marcellino +2 more

Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity

Clinical Journal of the American Society of Nephrology(2023)10.2215/cjn.0000000000000219

N/A

0.360DataRank · unranked

10 citations

Matthew Abramson, Victoria Gutgarts, Florin Marcel Musteata, Kinsuk Chauhan, Alecia N. Muwonge +13 more

Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignancies

BMC Medical Research Methodology(2025)10.1186/s12874-025-02617-y

N/A

0.165DataRank · unranked

2 citations

Vishal Bhatnagar, Brie N. Noble, Tingyu Chen, Mallorie H. Fiero, Ron Hoffman +11 more

Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implications

Critical Reviews in Oncology/Hematology(2023)10.1016/j.critrevonc.2023.104187

N/A

0DataRank · unranked

18 citations

Max L. Dougherty, Manasa Bhatta, John Mascarenhas, Bridget K. Marcellino, Daniel I. Nathan

Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial

Haematologica(2023)10.3324/haematol.2022.282411

N/A

0DataRank · unranked

17 citations

Lynda Foltz, Vikas Gupta, Robert P. Hasserjian, Taghi Manshouri, John Mascarenhas +15 more

Dasatinib nephrotoxicity correlates with patient-specific pharmacokinetics

medRxiv(2023)10.1101/2023.04.09.23288333

N/A

0DataRank · unranked

1 citations

Matthew Abramson, Victoria Gutgarts, Marcel F. Musteata, Kinsuk Chauhan, Alecia N. Muwonge +13 more

Diagnosis and Treatment of Polycythemia Vera

JAMA(2024)10.1001/jama.2024.20377

N/A

0DataRank · unranked

32 citations

Marina Kremyanskaya, John Mascarenhas, Ronald Hoffman, Douglas Tremblay

Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis

Blood(2024)10.1182/blood.2024025802

N/A

0DataRank · unranked

25 citations

Giovanni Barosi, Francesco Passamonti, Juan Carlos Hernández‐Boluda, Prithviraj Bose, Konstanze Döhner +33 more

Impact of gender representativeness in online symptom survey and clinical trial participation among patients with myeloproliferative neoplasms

Leukemia & lymphoma/Leukemia and lymphoma(2024)10.1080/10428194.2024.2356058

N/A

0DataRank · unranked

3 citations

Amylou C. Dueck, Heidi Kosiorek, Carolyn Mead‐Harvey, Eric A. Meek, Lauren J. Rogak +9 more

Myeloid neoplasms in inflammatory bowel disease: A case series and review of the literature

Leukemia Research Reports(2024)10.1016/j.lrr.2024.100458

N/A

0DataRank · unranked

1 citations

Daniel I. Nathan, Angela Liu, John Mascarenhas, Bridget K. Marcellino, David Mueller

Clonal Hematopoiesis of Indeterminate Potential in Crohn’s Disease and Ulcerative Colitis

Inflammatory Bowel Diseases(2025)10.1093/ibd/izae312

N/A

0DataRank · unranked

13 citations

Daniel I. Nathan, Daniela Guisado, Giulia Collatuzzo, Sushruta Iruvanti, Paolo Boffetta +6 more

Ring Chromosomes in Patients with Myeloid Neoplasms Are Associated with a Poor Response to Therapy

Acta Haematologica(2025)10.1159/000546757

N/A

0DataRank · unranked

0 citations

Ronald Hoffman, Daiva Ahire, John Mascarenhas, Bridget K. Marcellino, Douglas Tremblay +4 more

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

The Lancet Haematology(2020)10.1016/s2352-3026(20)30205-2

N/A

0DataRank · unranked

97 citations

Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal +47 more

The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis

Blood Advances(2020)10.1182/bloodadvances.2019001310

N/A

0DataRank · unranked

92 citations

Douglas Tremblay, Nicole Zubizarreta, Erin Moshier, Kevin Troy, Thomas D. Schiano +2 more

The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease

Inflammatory Bowel Diseases(2020)10.1093/ibd/izaa053

N/A

0DataRank · unranked

32 citations

Douglas Tremblay, Nicole Zubizarreta, Erin Moshier, Steven Naymagon, John Mascarenhas +2 more

A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinoma

iScience(2021)10.1016/j.isci.2021.102212

N/A

0DataRank · unranked

38 citations

Peter Smibert, Andrew Uzilov, Alexander Teague, Sindhura Gopinath, Yevgeniy Antipin +25 more

Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase

JCI Insight(2022)10.1172/jci.insight.156534

N/A

0DataRank · unranked

6 citations

Raajit K. Rampal, Cing Siang Hu, Joseph Tripodi, Noushin Farnoud, Bruce Petersen +12 more

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0276

N/A

0DataRank · unranked

34 citations

Anna Ritá Migliaccio, Heidi Kosiorek, Rupali Bhave, Jeanne Palmer, Andrew Kuykendall +29 more